CD8A and neoplasm: Altogether, these data establish the ability of our G47Δ-mIL12 virus to induce efficient in situ vaccine effects in promoting DC maturation and antigen presentation that eventually could be responsible for promoting CD8+ T cell responses in virus-injected and non-injected tumor lesions.